RHJA
LGND icon

Rice Hall James & Associates’s Ligand Pharmaceuticals LGND Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$38.3M Buy
337,348
+40,127
+14% +$4.56M 2.07% 9
2025
Q1
$31.2M Sell
297,221
-7,704
-3% -$810K 1.84% 12
2024
Q4
$32.7M Sell
304,925
-7,954
-3% -$852K 1.79% 13
2024
Q3
$31.3M Buy
312,879
+20,404
+7% +$2.04M 1.69% 14
2024
Q2
$24.6M Buy
292,475
+12,691
+5% +$1.07M 1.48% 16
2024
Q1
$20.5M Buy
279,784
+3,776
+1% +$276K 1.17% 21
2023
Q4
$19.7M Sell
276,008
-6,953
-2% -$497K 1.14% 22
2023
Q3
$17M Sell
282,961
-5,198
-2% -$311K 1.08% 22
2023
Q2
$20.8M Sell
288,159
-186
-0.1% -$13.4K 1.18% 21
2023
Q1
$21.2M Buy
288,345
+2,711
+0.9% +$199K 1.2% 22
2022
Q4
$19.1M Sell
285,634
-11,044
-4% -$738K 1.09% 22
2022
Q3
$25.5M Sell
296,678
-37,964
-11% -$3.27M 1.48% 13
2022
Q2
$29.9M Sell
334,642
-10,327
-3% -$921K 1.44% 15
2022
Q1
$38.8M Sell
344,969
-2,730
-0.8% -$307K 1.55% 16
2021
Q4
$53.7M Sell
347,699
-26,021
-7% -$4.02M 1.91% 11
2021
Q3
$52.1M Sell
373,720
-5,006
-1% -$697K 1.92% 8
2021
Q2
$49.7M Sell
378,726
-51,330
-12% -$6.73M 1.77% 11
2021
Q1
$65.6M Sell
430,056
-74,103
-15% -$11.3M 2.14% 7
2020
Q4
$50.1M Buy
504,159
+117,653
+30% +$11.7M 1.76% 15
2020
Q3
$36.8M Buy
386,506
+54,766
+17% +$5.22M 1.48% 16
2020
Q2
$37.1M Sell
331,740
-6,636
-2% -$742K 1.59% 15
2020
Q1
$24.6M Buy
338,376
+35,873
+12% +$2.61M 1.38% 18
2019
Q4
$31.5M Sell
302,503
-13,251
-4% -$1.38M 1.07% 26
2019
Q3
$31.4M Sell
315,754
-6,491
-2% -$646K 1.12% 25
2019
Q2
$36.8M Sell
322,245
-19,896
-6% -$2.27M 1.22% 17
2019
Q1
$43M Buy
342,141
+67,224
+24% +$8.45M 1.38% 14
2018
Q4
$37.3M Buy
274,917
+83,586
+44% +$11.3M 1.36% 15
2018
Q3
$52.5M Sell
191,331
-75,589
-28% -$20.7M 1.88% 7
2018
Q2
$55.3M Sell
266,920
-37,772
-12% -$7.83M 2.01% 5
2018
Q1
$50.3M Sell
304,692
-2,166
-0.7% -$358K 1.96% 5
2017
Q4
$42M Buy
306,858
+38,844
+14% +$5.32M 1.65% 10
2017
Q3
$36.5M Sell
268,014
-11,368
-4% -$1.55M 1.61% 6
2017
Q2
$33.9M Buy
279,382
+59,882
+27% +$7.27M 1.48% 7
2017
Q1
$23.2M Buy
219,500
+8,925
+4% +$945K 1.13% 11
2016
Q4
$21.4M Buy
210,575
+1,716
+0.8% +$174K 1.08% 22
2016
Q3
$21.3M Buy
208,859
+23,030
+12% +$2.35M 1.11% 15
2016
Q2
$22.2M Buy
185,829
+1,458
+0.8% +$174K 1.28% 10
2016
Q1
$19.7M Buy
184,371
+3,959
+2% +$424K 1.14% 22
2015
Q4
$19.6M Buy
180,412
+76,924
+74% +$8.34M 1.12% 21
2015
Q3
$8.86M Buy
103,488
+8,523
+9% +$730K 0.57% 59
2015
Q2
$9.58M Sell
94,965
-9,428
-9% -$951K 0.55% 62
2015
Q1
$8.05M Buy
+104,393
New +$8.05M 0.47% 71